医学
舌下免疫疗法
耳鼻咽喉科
过敏原
内科学
可视模拟标度
变应原免疫治疗
舌下给药
狭缝
过敏
麻醉
外科
免疫学
生物
遗传学
作者
Dandan Yu,Y Liu,Z. Y. Zheng,Jian Zhang,Lihua Gao,Meibian Zhang,Chuan He,Jinjin Hao,K J Zhang,Yan Feng
出处
期刊:PubMed
日期:2023-12-06
卷期号:57 (12): 1996-2001
标识
DOI:10.3760/cma.j.cn112150-20230711-00002
摘要
To study the efficacy and compliance analysis of pollen allergen drops in the treatment of allergic rhinitis. The method of single-center controlled was used to analyze the dates' results. From July 2021 to September 2021, 80 patients with seasonal allergic rhinitis were referred to the clinic of otorhinolaryngology in First Hospital of Shanxi Medical University.40 patients received sublingual immunotherapy (SLIT group), and the other 40 patients received symptomatic drug treatment as the control group. The total rhinoconjunctivitis symptom score (TRSS), the visual analogue scale(VAS), total medication score (TMS) and combined scores of medication and rhinoconjunctivitis symptoms (CSMRS) of the patient before the start of the treatment and after the first year of the treatment were compared to assess the efficacy of sublingual immunotherapy of Artemisia pollen. Follow the shedding during the study, the safety of the drug and the causes for compliance analysis were analyzed and recorded. The results of comparison with TRSS, VAS, TMS and CSMRS in two groups in the period of pretherapy were as follows: TRSS(12.393±3.023, 12.450±3.029,
科研通智能强力驱动
Strongly Powered by AbleSci AI